Revenue Breakdown
Composition ()
No data
Revenue Streams
Omnicell Inc (OMCL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Connected devices, software licenses, and other, accounting for 47.7% of total sales, equivalent to $138.62M. Other significant revenue streams include Technical services and SaaS and Expert Services. Understanding this composition is critical for investors evaluating how OMCL navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Omnicell Inc maintains a gross margin of 41.51%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 0.38%, while the net margin is -0.65%. These profitability ratios, combined with a Return on Equity (ROE) of 0.17%, provide a clear picture of how effectively OMCL converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, OMCL competes directly with industry leaders such as ASGN and QUBT. With a market capitalization of $1.66B, it holds a significant position in the sector. When comparing efficiency, OMCL's gross margin of 41.51% stands against ASGN's 27.21% and QUBT's 32.81%. Such benchmarking helps identify whether Omnicell Inc is trading at a premium or discount relative to its financial performance.
